Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype
Funds turning a preliminary drug, biologic or combination-product lead into a combination-product prototype for heart, lung, blood or sleep disease.
A preliminary lead compound is not a product yet — someone still has to build it into something that could plausibly become a combination product. This notice funds that build-out.
It sits inside NHLBI's Catalyze Program, and this specific initiative covers small molecules, biologics and combination products for heart, lung, blood and sleep disease. It funds the early translational work needed to…
Development of a preliminary product or lead series into a combination-product prototype for small molecule, biologic and combination-product candidates against heart, lung, blood or sleep disease, under NHLBI's Catalyze Program.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up